Upcoming Event: Prostate Cancer 101: Understanding the Journey Diagnosis, Treatment, and Survival

By

Join us for a free presentation to learn more about the latest developments in prostate cancer. Dr. Wilkinson will discuss the most advanced diagnostic tools and current trends in treatment including multiparametric MRI, genomic classification, when to use active surveillance, and how to preserve quality of life after a prostate diagnosis.

Friday, September 20th from  930-11a

Hosted by: Provision CARES Proton Therapy Knoxville, 6450 Provision CARES Way, Knoxville, TN 37909

RSVP: To reserve your seat, please RSVP to Jenni Turner at 865.321.4539 or jenni.turner@provisionhp.com

Free PSA level screenings offered throughout East Tennessee

By

Eddie Check® and the Provision CARES Foundation Team Up for Blood Drive and Free PSA Screenings

Available at 16 different East Tennessee locations across 10 counties on September 12th & 13th.

Unbelievably, One in nine men will be diagnosed with prostate cancer during his lifetime – and one in 41 will die from it. Prostate cancer is second only to skin cancer as the most common cancer in American men and second only to lung cancer as the leading cancer-based cause of death in American men. The American Cancer Society estimates that in the U.S. during 2019, about 174,650 new cases of prostate cancer will be diagnosed and 31,620 men will die from it.

But there’s still good news. If prostate cancer is caught early, the 5-year survival rate is nearly 100%. The numbers say it all: Get tested!  Prostate cancer is rare before age 40, so if you are 40 or older, the first step is a free, simple PSA screening that only requires a blood sample. “PSA” stands for prostate-specific antigen, a protein produced by prostate cells. The PSA test is done to help diagnose and follow prostate cancer in men.  No certain PSA level is called normal or abnormal, and an elevated level does not mean you have prostate cancer – only a biopsy can diagnose cancer. Always discuss PSA test results with your doctor and be sure to have a digital rectal exam (DRE), as about 6% of men with prostate cancer continue to have normal PSA.

In 2004, Rockford-based Nisus Corporation, a manufacturer of green products for the pest control and wood preservation industries, teamed up with area hospitals and MEDIC Regional Blood Center to create Eddie Check, an annual event that adds free PSA screening for prostate cancer to blood drives. It was a simple strategy using MEDIC’s already existing resources to make it fast and easy for men to get a blood sample drawn for the screening. Nisus has a personal stake in the fight; marketing vice president Jim Gorman is a prostate cancer survivor, while company president Kevin L. Kirkland lost his father, Eddie Kirkland, to the disease. In fact, “Eddie Check” is named for Eddie Kirkland.

Once again, Nisus, MEDIC, Provision CARES Proton Therapy, and Provision CARES Foundation join with sponsors WIVK FM 107.7, Sports Radio WNML 99.1 FM & 990 AM, NewsTalk 98.7 FM, WVLT, and Abacus Arts, Inc.

Sites and Locations

Thursday, September 12

Friday, September 13

Am I at Risk for Prostate Cancer

Am I at risk for prostate cancer?

By

September is Prostate Cancer Awareness Month.  It is important to know if you are at risk and if you should get an annual Prostate-Specific Antigen (PSA) level test.

In Tennessee, as well as the United States, prostate cancer has the second highest new cancer rate overall and is the number one cancer for new cancer types among men.(1)    According to the Center for Disease Control (CDC), there are an estimated 3,110,403 men living with prostate cancer in the US.  Based on their 2014-2016 data, approximately 11.6% of men will be diagnosed with prostate cancer at some point in their lifetime.  According to SEER, there will be an estimated 174,650 new cases of prostate cancer in 2019 with an estimated 31,620 deaths from prostate cancer.  The five year survival rate for prostate

Prostate cancer is most frequently diagnosed among men aged 65-74 with a median age of 66.  However, 9.2% of new prostate cancer cases are among men under the age of 55.(2)

In addition to age, other factors can increase in the risk of being diagnosed with prostate cancer including family history, genetic factors, race, lifestyle and dietary habits.

If an immediate family member such as your father or brother have been diagnosed with prostate cancer, then your risk of developing prostate cancer is 2 to 3 times higher than normal.  Your risk increases with each relative that has been diagnosed with prostate cancer.  Your risk will also increase if two or more close relatives on the same side of the family have been diagnosed with prostate cancer before the age of 55.(3)

African American men have a higher risk of prostate cancer and are more likely to be diagnosed at a younger age and have been found to have a more aggressive tumor.

There have not been any studies to prove that diet and nutrition has any direct correlation with developing prostate cancer.  However, if a male who is overweight is diagnosed with prostate cancer, they are at a greater risk for developing a more aggressive prostate cancer.

While there can be lifestyle and dietary habits that can increase your risk of prostate cancer, there are a few myths that have been rumored to increase your risk of prostate cancer.   Sexual activity level is a non-factor as well as having a vasectomy.  Alcohol is another non-risk factor for prostate cancer.

If you do have any of these risk factors, it is important to have your PSA level checked annually.  If you do have an elevated PSA level, your doctor can provide information on additional testing to confirm your diagnosis.

Source:

(1) Center for Disease Control.  Prostate Cancer Statistics.  https://www.cdc.gov/cancer/prostate/statistics/index.htm

(2) National Cancer Institute.  Surveillance, Epidemiology, and End Results Program.  Cancer Stat Facts:  Prostate Cancer. https://seer.cancer.gov/statfacts/html/prost.html

(3) Cancer.Net.  Prostate Cancer Statistics.  https://www.cancer.net/cancer-types/prostate-cancer/statistics

Upcoming Events: Prostate Cancer 101: Understanding the Journey Diagnosis, Treatment, and Survival

By

Join us for a free presentation to learn more about the latest developments in prostate cancer. Dr. Wilkinson will discuss the most advanced diagnostic tools and current trends in treatment including multiparametric MRI, genomic classification, when to use active surveillance, and how to preserve quality of life after a prostate diagnosis.

Friday, July 26th from 930-11a and Friday August 23rd from 930-11a

Hosted by: Provision CARES Proton Therapy Knoxville, 6450 Provision CARES Way, Knoxville, TN 37909

RSVP: To reserve your seat, please RSVP to Jenni Turner at 865.321.4539 or jenni.turner@provisionhp.com

Prostate Cancer 101: Understanding the Journey Diagnosis, Treatment, and Survival

By

Join us for a free presentation to learn more about the latest developments in prostate cancer. Dr. Wilkinson will discuss the most advanced diagnostic tools and current trends in treatment including multiparametric MRI, genomic classification, when to use active surveillance, and how to preserve quality of life after a prostate diagnosis.

Thursday, May 9th at 6:30pm or Friday, May 17th at 9:30am

Hosted by: Provision CARES Proton Therapy Knoxville, 6450 Provision CARES Way, Knoxville, TN 37909

RSVP: To reserve your seat, please RSVP to Jenni Turner at 865.321.4539 or jenni.turner@provisionhp.com

15th Annual Eddie Check Event

By

Free PSA Test and Blood Drive at Provision CARES Proton Therapy Knoxville September 13th and 14th!

Eddie Check is celebrating its 15th anniversary of offering men across East Tennessee a free PSA test and raising awareness for prostate cancer. On September 13th and 14th, you are invited to get a free screening test for prostate cancer as well participate in a blood drive. (more…)

Risk Factors for Prostate Cancer

Risk Factors for Prostate Cancer can increase due to Age, Race and Family History

By

Early detection of cancer can be the next best thing to prevention. There are several widely known risk factors for prostate cancer that may increase the probability of a man to develop prostate cancer. Age, race and family history are the most common today. According to ASCO Cancer.Net, “Prostate cancer that runs in a family, called familial prostate cancer, occurs about 20% of the time.” Sources say that shared genes, similar lifestyles and environments play a role in developing familial prostate cancer. Hereditary prostate cancer accounts for almost 5% of cases. This type of gene mutation is passed down within family generations. A few characteristics for hereditary prostate cancer could include: (more…)

Dale C. Prostate Cancer

Proton Stories: Dale C.

By

Dale Clayton first heard about Provision CARES Proton Therapy through a TV commercial. Not knowing he had cancer, he tucked the words “proton therapy” in the back of his mind, hoping that he would never have to remember them. It was February 2015 when Mr. Clayton learned he had prostate cancer. Dale had always been proactive when it came to his health. He said, “my mom always taught me to be proactive.” He went in for regular checkups, yearly physicals, and was well aware of his PSA and gleason score. At his appointment in 2015, all test scores came back normal, but he insisted on a biopsy, just to be sure. Both the doctor and Clayton were shocked, his biopsy came back positive. Dale was diagnosed with low risk, non-aggressive prostate cancer and decided on active surveillance.

Two and a half years later, things started to change. His PSA remained normal but his biopsy showed the cancer had doubled in size. “It’s a miracle we found it,” said Clayton, “I believe God placed the right doctors, urologists, and friends around me to help me make an informed treatment decision.” He researched prostate cancer and treatment options, from surgery to brachytherapy to protons, and there were two things that were very significant to his treatment decision process:

  1. Cure Rate
  2. Quality of Life

(more…)

National particle therapy conference boosts proton therapy’s profile

By

Proton therapy got positive billing at the recent Particle Therapy Cooperative Group, as researchers from across the country presented findings that showed proton therapy reduced potentially life-altering side effects and improved survival rates for cancer patients.

The National Association for Proton Therapy (NAPT) released a summary of the results, which included the findings of studies focused on esophageal, prostate and breast cancer. (more…)